Patent · US Active

Thyroid receptor ligands

US8263659B2 · kind B2 · utility

0Cited by

42References

11Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Denis E. Ryono · Princeton, US
Jon J. Hangeland · Levittown, US
Todd J. Friends · Bordentown, US
Tamara Dejneka · Skillman, US
Pratik Devasthale · Plainsboro, US
Yolanda Caringal · Lawrenceville, US
Minsheng Zhang · Hackettstown, US
Arthur M. P. Doweyko · Long Valley, US
Johan Malm · Älta, SE
Andrei Sanin · Kalmar, SE

Key dates

Filing date	May 21, 2009
Grant date	Sep 11, 2012
Priority date	—
Expiry date	Oct 23, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolism dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described in the general formula I below is administered in a therapeutically effective amount:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.